Report Categories Report Categories

Report Categories

industry Category

All

Total: 3 records, 1 pages

Global Moxifloxacin Hydrochloride and Sodium Chloride Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Moxifloxacin Hydrochloride and Sodium Chloride Injection

According to our (Global Info Research) latest study, the global Moxifloxacin Hydrochloride and Sodium Chloride Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Moxifloxacin Hydrochloride and Sodium Chloride Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 26 Feb 2023

date Pharma & Healthcare

new_biaoQian Moxifloxacin Hydrochloride and Sodium Chloride Injection

Moxifloxacin Hydrochloride and Sodium Chloride Injection The main component of this product is moxifloxacin hydrochloride, which is a yellow clear liquid. It is used for upper and lower respiratory tract infections of adults (≥18 years old), such as acute sinusitis, chronic bronchitis Acute attack, community-acquired pneumonia; and skin and soft tissue infections. Complex abdominal infections include mixed bacterial infections, such as abscesses.

USD3480.00

Add To Cart

Add To Cart

Global Moxifloxacin Hydrochloride and Sodium Chloride Injection Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Pharma & Healthcare

new_biaoQian Moxifloxacin Hydrochloride and Sodium Chloride Injection

The global Moxifloxacin Hydrochloride and Sodium Chloride Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

According to our (Global Info Research) latest study, the global Moxifloxacin Hydrochloride and Sodium Chloride Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

Moxifloxacin Hydrochloride and Sodium Chloride Injection The main component of this product is moxifloxacin hydrochloride, which is a yellow clear liquid. It is used for upper and lower respiratory tract infections of adults (≥18 years old), such as acute sinusitis, chronic bronchitis Acute attack, community-acquired pneumonia; and skin and soft tissue infections. Complex abdominal infections include mixed bacterial infections, such as abscesses.

USD3480.00

addToCart

Add To Cart

The global Moxifloxacin Hydrochloride and Sodium Chloride Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart